I think it is as important for clinicians as it is for patients, so please make sure and share this information with your doctors
Hypertension (high blood pressure)
Triple GIP/GLP-1/glucagon receptor co-agonists The success of dual receptor agonists for the treatment of type 2 diabetes and obesity in clinical trials, including the approval of one such drug by the FDA and EMA (currently only for type 2 diabetes), has prompted the search for new combinatorial approaches
Henaut L, Massy ZA
Oral GLP-1 Drops vs Injection, Pros, Cons, and Reality Explained Oral GLP-1 options have generated a lot of buzz because they promise a needle-free path to the same appetite-suppressing benefits as weekly injections
For example, CJC-1295 and Ipamorelin are often stacked for broader growth hormone effects, though the visceral-fat evidence for them is thinner than for tesamorelin